跳至主要内容
临床试验/NCT06014164
NCT06014164已完成不适用

Qualitative Study of the Self-administered Therapeutic Use of Psychedelics in People With Psychiatric Disorders

University Hospital, Toulouse1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年11月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Experiences of people using psychedelic substances

研究概览

简要总结

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
  • Patients used psychedelic or related substances in order to treat psychiatric symptoms
  • Patients have given their oral non-opposition
  • Patients affiliated to a social security scheme

排除标准

  • Patients who don't speak or understand French
  • Patients under protection, guardianship or curators

研究组 & 干预措施

Patients using psychedelic substances

Adult patients self-administering psychedelic substances in psychiatric disorders

干预措施: Interview (Diagnostic Test)

结局指标

主要结局

Experiences of people using psychedelic substances

时间窗: Baseline

Experiences description of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview

次要结局

  • Profile of people using psychedelic substances(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Qualitative Study About Psychedelics Using in... | 临床试验